Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Understanding the immunopathophysiology of polymyalgia rheumatica: implications for treatment.
Journal: Annals of the rheumatic diseases
Published: March 21, 2025
Health Disparities in Rheumatology in the United States.
Journal: Open access rheumatology : research and reviews
Published: August 28, 2024
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review.
Journal: Advances in therapy
Published: December 20, 2023
Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.
Journal: Rheumatology and therapy
Published: January 04, 2023
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis.
Journal: The Journal of rheumatology
Published: March 29, 2022
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists.
Journal: Clinical rheumatology
Published: October 18, 2021
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Journal: Rheumatology and therapy
Published: May 05, 2021
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study.
Journal: Rheumatology and therapy
Published: February 15, 2021
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.
Journal: Rheumatology (Oxford, England)
Published: October 21, 2020
Last Updated: 09/26/2026